Devin Wenig, Director at NASTECH PHARMACEUTICAL CO INC (NSTK), sold 3,000 shares at $17.75 ($53K) on 2006-11-01, disclosed to the SEC on 2006-11-02.
Scheduled sale ($53k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.45 | 100 | $2K | 3.3% |
| 2 | $17.50 | 300 | $5K | 9.9% |
| 3 | $17.52 | 306 | $5K | 10.1% |
| 4 | $17.53 | 100 | $2K | 3.3% |
| 5 | $17.54 | 500 | $9K | 16.6% |
| 6 | $17.57 | 300 |
| $5K |
| 10.0% |
| 7 | $17.58 | 100 | $2K | 3.3% |
| 8 | $17.59 | 100 | $2K | 3.3% |
| 9 | $17.61 | 94 | $2K | 3.1% |
| 10 | $17.65 | 200 | $4K | 6.7% |
| 11 | $17.75 | 500 | $9K | 16.8% |
| 12 | $17.80 | 400 | $7K | 13.5% |
| Total | $17.62 avg | 3,000 | $53K | 100% |
| Filing → |
| EBAY | SELL | 2019-07-03 | $398K | — | Filing → |
| EBAY | SELL | 2018-02-08 | $11.5M | — | Filing → |
| EBAY | SELL | 2013-10-31 | $2.4M | — | Filing → |